Skip to main content

Rsv Vaccine Pref3, Recombinant Side Effects

Medically reviewed by Drugs.com. Last updated on Jun 6, 2024.

Applies to rsv vaccine pref3, recombinant: intramuscular powder for suspension.

Other side effects

Some side effects of rsv vaccine pref3, recombinant may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

  • bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • difficulty in moving
  • headache
  • joint pain
  • muscle aches, cramps, pains, or stiffness
  • swollen joints

Serious side effects

Along with its needed effects, rsv vaccine pref3, recombinant may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking rsv vaccine pref3, recombinant:

Less common side effects

Incidence not known

For healthcare professionals

Applies to rsv vaccine pref3, recombinant: intramuscular powder for injection.

General adverse events

The most commonly reported side effects include injection site pain, fatigue, myalgia, and headache.[Ref]

Cardiovascular

Dermatologic

Gastrointestinal

Hematologic

Hypersensitivity

Local

Grade 3 localized pain included significant pain at rest and pain that prevented normal everyday activities.[Ref]

Musculoskeletal

Grade 3 arthralgia and myalgia included events that prevented normal activity.[Ref]

Nervous system

Grade 3 headache included events that prevented normal activity.[Ref]

Other

Grade 3 fatigue included events that prevented normal activity.

There was no evidence of a causal relationship between this vaccine and death based on available data, as causes of death in the participants were consistent with those generally reported within their age cohort.[Ref]

Respiratory

References

1. (2023) "Product Information. Arexvy (obsolete) (RSV vaccine, preF A-preF B, recombinant)." GlaxoSmithKline, 1

2. (2024) "Product Information. Arexvy (RSV (respiratory syncytial virus) vaccine preF3, recombinant)." GlaxoSmithKline Australia Pty Ltd, Version 1.0

3. (2024) "Product Information. Arexvy (RSV vaccine preF3, recombinant)." GlaxoSmithKline UK Ltd

Frequently asked questions

Further information

Rsv vaccine pref3, recombinant side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.